Immediate Impact

3 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
Late-stage Functionalization for Improving Drug-like Molecular Properties
2023 Standout
2 intermediate papers

Works of S. Seeber being referenced

Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors
2002
Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.
1997

Author Peers

Author Last Decade Papers Cites
S. Seeber 157 85 256 95 14 419
Graziella Malaponte 241 46 125 47 10 476
Krakoff Ih 154 47 196 52 24 435
Yang-Hui Huang 293 44 300 51 29 463
Sarah Lowndes 112 88 155 47 10 443
Giuditta Cuccuru 266 45 184 38 17 494
Jeffrey A. Schneider 192 71 86 44 16 506
Ratna Kumari 196 32 125 113 16 436
Sung-Han Hsiao 288 41 300 44 21 455
K Csóka 247 46 206 39 18 501
Xiaomin Lu 245 52 215 155 23 507

All Works

Loading papers...

Rankless by CCL
2026